// App-Quantinova.ai

BSH19‐PO‐194 : Post‐transplant flow cytometry MRD predicts relapse in AML and high risk MDS patients treated with allogeneic haematopoietic stem cell transplant

Researchers

Presenter

  • H. Wood

Principal Investigators

  • K. Sanchez

  • V. Potter

  • A. Kulasekararaj

  • D. Yallop

  • S. Kassam

  • R. Ireland

  • G. Mufti

  • A. Dunlop

Medical Centers

  • Department of Hematology,

  • Kings College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute promyelocytic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Vidaza

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved